Printer Friendly
The Free Library
19,573,962 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

189 Deals Made by Sanofi-Aventis and Its Subsidiaries with 214 Partnering Companies between 2000 and 2005.


DUBLIN Dublin, city, Republic of Ireland
Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River.
, Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles.  -- Research and Markets (http://www.researchandmarkets.com/reports/c26245) has announced the addition of Sanofi-Aventis Sanofi-Aventis (Euronext: SAN, NYSE: SNY), headquartered in Paris, France, is one of the five largest pharmaceutical companies in the world, along with Pfizer, Bristol-Myers Squibb, Novartis, and GlaxoSmithKline.  Deals Briefing to their offering.

Sanofi-Aventis Deals briefing provides an in-depth in-depth
adj.
Detailed; thorough: an in-depth study.


in-depth
Adjective

detailed or thorough: an in-depth analysis

 view of the 189 deals made by Sanofi-Aventis and its subsidiaries with 214 partnering companies between 2000 and 2005, in a clear and accessible PDF (Portable Document Format) The de facto standard for document publishing from Adobe. On the Web, there are countless brochures, data sheets, white papers and technical manuals in the PDF format.  format.

Chapter 1: Company profile

An overview of the company, including contact details, a summary of business and partnering interests, and a review of management.

Chapter 2: Financial data and deals overview

A summary of the company's financial status and overview of the numbers of deals by deal type, therapy focus, deal stage and industry sector.

Chapter 3: Summary of deals

A comprehensive overview listing deals by partner company, therapy focus and development stage, with a full index of all the deals announced.

Chapter 4: List of deals

A detailed listing of all the company's deals and alliances announced between January January: see month.  2000 and July 2005.

Every deal is fully categorized cat·e·go·rize  
tr.v. cat·e·go·rized, cat·e·go·riz·ing, cat·e·go·riz·es
To put into a category or categories; classify.



cat
, includes a detailed description, and includes financials such as headline value, upfront payments and royalty rates, where disclosed.

Sanofi-Aventis Deals briefing brings all relevant partnering deals into one place, providing a reference to deal making by Sanofi-Aventis.

This report provides: a financial summary table detailing the yearly total revenues, pharma revenues, R&D spend and profit of the company; and a series of tables detailing the number of deals made by deal type, by therapy focus, by development stage and by industry sector.
- Who should read this report?
    This report is essential reading for board and executive
management, and individuals in:
    - Business development
    - Licensing/partnering
    - Deal making
    - Business strategy
    - Marketing and promotion
    - Distribution and manufacturing (including contract services).

    Companies & Subsidiaries:
    Aventis
    Aventis Bulk SpA
    Aventis Pharma
    Aventis Pharma Deutschland GmbH
    Aventis Pharmaceuticals
    Dermik Laboratories
    Ela Medical
    Hoechst Marion Roussel
    Porges
    Sanofi-Synthelabo
    Sanofi-Synthelabo-Lek
    Xzillion Proteomics GmbH & Co KG


For more information visit http://www.researchandmarkets.com/reports/c26245
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 27, 2005
Words:320
Previous Article:Light Reading Webinar: Ethernet in Access Networks: A Technology & Market Update.
Next Article:View the Only Source That Provides Handset Forecasts for 18 Markets in Latin America.
Topics:



Related Articles
Sanofi-aventis Japan Acquires Production and Sales Rights of Ancaron Antiarrhythmic Agent from Taisho Pharmaceutical.
Drug giant picks NJ for 670,000 s/f HQ.
Astellas Pharma, Sanofi-aventis Japan to Co-promtoe Myslee Tablet, Hypnotic Drug.
SANOFI-AVENTIS/REGENERON EXPAND VEGF TRAP PACT TO JAPAN.
Hillier Architecture: Ivan Rosa.
Gramercy buys share of New Jersey corporate complex.
Securities firm subleases space at 90 Park.
Hitachi leases last block at 90 Park Avenue.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles